MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:ONWRY)

5.106 UNCHANGED
Streaming Delayed Price Updated: 9:34 AM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ONWRY

News headline image
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
From ONWARD Medical NV
Via GlobeNewswire
News headline image
Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
From ONWARD Medical NV
Via GlobeNewswire
News headline image
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants
From ONWARD Medical NV
Via GlobeNewswire
News headline image
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions
From ONWARD Medical NV
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story